DM
David C. Myles
Ch. Discov. & Non-Clin Dev Off

David C. Myles insider trades: Olema Pharmaceuticals (OLMA) stock sales

Ch. Discov. & Non-Clin Dev Off, Olema Pharmaceuticals Last trade Jan 14, 2026 15 Form 4 filings
$4.7M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 14, 2026OLMA↓ Sell$2.8M
Jan 12, 2026OLMA↓ Sell$283K
Dec 19, 2025OLMA↓ Sell$1.6M
Dec 11, 2024OLMA↓ Sell$235K
Nov 22, 2023OLMA↓ Sell$196K
Nov 8, 2023OLMA↓ Sell$4K
Nov 3, 2023OLMA↓ Sell$161K
Sep 19, 2023OLMA↓ Sell$253K
Dec 10, 2021OLMA↓ Sell$103K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OLMA insiders

Open-market trades in the last 12 months

About David C. Myles's insider trades

David C. Myles is Ch. Discov. & Non-Clin Dev Off at Olema Pharmaceuticals (OLMA). Since Dec 10, 2021, David has reported no open-market purchases and 9 sales worth $5.6M on SEC Form 4. In the last 12 months: 3 sales ($4.7M).

Their filings also include grants and awards (8 filings), option exercises (1 filing), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OLMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.